Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 7.37 B

Share Price

USD 148.74

Avg Daily Volume

920,453

Change (1 day)

-0.69%

Change (1 year)

-26.34%

Change (YTD)

-19.43%

Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 28, 2025: 2.44%

Charles River Laboratories International, Inc. EBIT Margin is 2.44% for the Trailing 12 Months (TTM) ending June 28, 2025, a -85.28% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 29, 2024 was 16.56%, a -9.04% change year over year.
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 01, 2023 was 18.21%, a 10.27% change year over year.
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 25, 2022 was 16.51%, a -8.30% change year over year.
Charles River Laboratories International, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 26, 2021 was 18.00%, a 23.69% change year over year.